EFTA01368502.txt Text dataset_10 View on DOJ

Illegal Activity
none
Blackmail
none
Date
2015-08-14
Document Type
email
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:43
Summary
Vahe Stepanian informs Jeffrey about Avalanche Bio's stock decline after scrapping a Phase 2b trial, noting Southern Financial's unrealized loss on its AAVL investment. He asks Jeffrey how he would like to proceed given the situation.
Metadata
Subject
FW: (BFW) Avalanche Bio Falls After Scrapping Plans for Ph.
Sender
Vahe Stepanian
Recipients
jeffrey E. ueevacation mail.corn
Document ID
DB-SDNY-0060256 SDNY_GM_00206440
Date
2015-08-14
Relationships 2
Entity 1RelationshipEntity 2Description
Vahe Stepanian email correspondence Jeffrey E. ueevacation Vahe Stepanian is informing Jeffrey about the stock performance of Avalanche Bio.
Southern Financial investment Avalanche Bio Southern Financial holds a long position in Avalanche Bio stock.
Notable Quotes 2
The stock is down —25% today to 510.289 on the back of news that it plans to scrap a planned Phase 2b trial
Recall that Southern Financial is long 10,000 AAVL @ $39.86, purchased 4/20/2015 (unrealized loss -5295k).
Financial Information
Amounts:510.28939.86-5295k
Assets:
  • AAVL stock
Transactions:
  • Southern Financial is long 10,000 AAVL @ $39.86, purchased 4/20/2015
Raw Analysis JSON click to expand
Themes
Financial transactions/money flowBusiness dealingsCommunications/correspondence
Organizations 4
Southern FinancialAvalanche BioDEUTSCHE BANK SECURIBloomberg Finance LP
Financial Entities 1
Bloomberg
Text Analysis
Tone
Informative
Purpose
To inform Jeffrey about the stock performance of Avalanche Bio and its impact on Southern Financial's investment.
Significance
The email provides information about a significant drop in Avalanche Bio's stock price and its potential financial implications for Southern Financial.
File Info
File Name
EFTA01368502.txt
Dataset
dataset_10
Type
Text
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:43:16.249514
DOJ Source
View on DOJ